Related references
Note: Only part of the references are listed.Contribution of IL-17-producing γδ T cells to the efficacy of anticancer chemotherapy
Yuting Ma et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Preclinical evaluation of ex vivo expanded/activated gamma delta T cells for immunotherapy of glioblastoma multiforme
Nichole L. Bryant et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Engineered drug-resistant immunocompetent cells enhance tumor cell killing during a chemotherapy challenge
Anindya Dasgupta et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Combination of Intensive Chemotherapy and Anticancer Vaccines in the Treatment of Human Malignancies: The Hematological Experience
Knut Liseth et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice
Rupal Ramakrishnan et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Chemotherapy Delivered After Viral Immunogene Therapy Augments Antitumor Efficacy Via Multiple Immune-mediated Mechanisms
Zvi G. Fridlender et al.
MOLECULAR THERAPY (2010)
Acquired Resistance to Temozolomide in Glioma Cell Lines: Molecular Mechanisms and Potential Translational Applications
Jihong Zhang et al.
ONCOLOGY (2010)
U87MG Decoded: The Genomic Sequence of a Cytogenetically Aberrant Human Cancer Cell Line
Michael James Clark et al.
PLOS GENETICS (2010)
Treg depletion with a low-dose metronomic temozolomide regimen in a rat glioma model
Claire Banissi et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
gamma delta T cells as immune effectors against high-grade gliomas
Lawrence S. Lamb
IMMUNOLOGIC RESEARCH (2009)
Directed Engineering of a High-expression Chimeric Transgene as a Strategy for Gene Therapy of Hemophilia A
Christopher B. Doering et al.
MOLECULAR THERAPY (2009)
Characterization and immunotherapeutic potential of γδ T-cells in patients with glioblastoma
Nichole L. Bryant et al.
NEURO-ONCOLOGY (2009)
Combined modality immunotherapy and chemotherapy: a new perspective
Rupal Ramakrishnan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy
Nadia Guerra et al.
IMMUNITY (2008)
NKG2D ligands:: key targets of the immune response
Segundo Gonzalez et al.
TRENDS IN IMMUNOLOGY (2008)
Immunological aspects of cancer chemotherapy
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Decoding dangerous death: how cytotoxic chemotherapy invokes inflammation, immunity or nothing at all
R. G. van der Most et al.
CELL DEATH AND DIFFERENTIATION (2008)
Enhancing efficacy of therapeutic vaccinations by combination with other modalities
James L. Gulley et al.
VACCINE (2007)
Complete regression of large solid tumors using engineered drug-resistant hematopoietic cells and anti-CD137 immunotherapy
Douglas W. McMillin et al.
HUMAN GENE THERAPY (2006)
A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer
PM Arlen et al.
CLINICAL CANCER RESEARCH (2006)
Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer
SJ Antonia et al.
CLINICAL CANCER RESEARCH (2006)
HLA-E protects glioma cells from NKG2D-mediated immune responses in vitro: Implications for immune escape in vivo
J Wischhusen et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)
Opinion - Immunotherapy and chemotherapy - a practical partnership
RA Lake et al.
NATURE REVIEWS CANCER (2005)
Migration of Vδ1 and Vδ2 T cells in response to CXCR3 and CXCR4 ligands in healthy donors and HIV-1-infected patients:: competition by HIV-1 Tat
A Poggi et al.
BLOOD (2004)
Intracavitary placement of autologous lymphokine-activated killer (LAK) cells after resection of recurrent glioblastoma
RO Dillman et al.
JOURNAL OF IMMUNOTHERAPY (2004)
Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma
JS Yu et al.
CANCER RESEARCH (2004)
Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus-based lentiviral vector system
H Hanawa et al.
BLOOD (2004)
Human alloreactive CTL interactions with gliomas and with those having upregulated HLA expression from exogenous IFN-γ or IFN-γ gene modification
SB Read et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2003)
Current and future strategies for the treatment of malignant brain tumors
MG Castro et al.
PHARMACOLOGY & THERAPEUTICS (2003)
Combinations of anticancer drugs and immunotherapy
MS Mitchell
CANCER IMMUNOLOGY IMMUNOTHERAPY (2003)
Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes
ME Dudley et al.
SCIENCE (2002)
T cell antigen receptor engagement and specificity in the recognition of stress-inducible MHC class I-related chains by human epithelial γδ T cells
J Wu et al.
JOURNAL OF IMMUNOLOGY (2002)
Targeting of tumor cells for human γδ T cells by nonpeptide antigens
Y Kato et al.
JOURNAL OF IMMUNOLOGY (2001)
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
A Diefenbach et al.
NATURE (2001)
Immune response induced by retrovirus-mediated HSV-tk/GCV pharmacogene therapy in patients with glioblastoma multiforme
NG Rainov et al.
GENE THERAPY (2000)
Share Paper
